PUBLIC CONTRACT · 2022

Aquisição de medicamentos derivados do plasma resultantes de processo de fracionamento de plasma humano exclusivamente português

Contract value: €2,406,738.00
Signed on: 16 May 2022
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9270506

PUBLISHED SUBJECT

Parties involved

Contracting body: Instituto Português do Sangue e da Transplantação, I. P.
Awardee: Octapharma-Prod Farmacêuticos, Lda; - - Octapharma AG, Sociedade Comercial de Direito Suiço
Place of performance: Portugal, Porto, Porto; Portugal, Coimbra, Coimbra; Portugal, Lisboa, Lisboa
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: Octapharma-Prod Farmacêuticos, Lda · Tax ID 502820780
Awardee: - - Octapharma AG, Sociedade Comercial de Direito Suiço

Values and timeline

Contract price: €2,406,738.00
Procedure base price: €2,450,000.00
Total effective price: Not reported on Portal BASE
Publication date: 20 May 2022
Award date: 6 May 2022
Signing date: 16 May 2022
Performance period: 180 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33141520-1 - Derivados do plasma
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5925303

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts